Please login to the form below

Not currently logged in
Email:
Password:

Drug industry forms disaster response group

Rx Response, a programme designed to support the delivery of medicines during a disaster or severe public health emergency, was launched today by healthcare organisations involved in the manufacture, distribution and dispensing of pharmaceutical products

Rx Response, a programme designed to support the delivery of medicines during a disaster or severe public health emergency, was launched today by healthcare organisations involved in the manufacture, distribution and dispensing of pharmaceutical products.

Billy Tauzin, a former US representative from Louisiana, and now president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) said: "During a disaster, it is vital that systems are in place to assist with the continued delivery of medicines to hospitals, healthcare providers and patients in need."

In the past, when the pharmaceutical supply chain was disrupted, there was no single forum for suppliers to convene and share information. Rx Response will expedite information sharing among its partners, community volunteer relief organisations, as well as local, state and federal agencies responding to major disasters.

The partnership includes the American Hospital Association, American Red Cross, Biotechnology Industry Organisation, Healthcare Distribution Management Association, National Association of Chain Drug Stores, National Community Pharmacists Association and PhRMA.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics